Introducing new product formulations in the medical device industry demands more than just innovation — it requires clear evidence that performance is consistent, reliable, and compliant from the very start. One leading manufacturer partnered with Emendo R&D to strengthen this process with advanced statistical consulting medical devices.
The challenge lay in demonstrating product equivalence while addressing batch-to-batch variability and test method uncertainty. Without the right statistical analysis framework, the risk of inconclusive or unreliable conclusions was high.
By applying structured study design, leveraging gauge R&R analysis, and building a centralized approach to data handling, we created a foundation for confident decision-making in formulation development.